Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion type Assertion NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_head.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion evidence source_evidence_literature NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion SIO_000772 23806066 NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion wasDerivedFrom befree-20140225 NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.
- NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion wasGeneratedBy ECO_0000203 NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.